Clinical Trials Browser

Phase 2 × Neoplasms × encorafenib × Clear all

NCT03915951 2025-11-17

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

Phase 2 Completed

98 enrolled 18 charts 1 FDA

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT05304546 2025-07-22

MK3475-C01

Phase 2 Completed

Melanoma, Neoplasms

NCT05097378 2021-10-28

PREMIUM

Phase 2 Unknown

Melanoma, Neoplasms